Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-05-12

FDA Approved: CLINDAMYCIN PHOSPHATE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)

View source ↗

Summary

FDA approved the supplemental application for clindamycin phosphate (Padagis Israel Pharmaceuticals Ltd), reflecting approval of the supplement to update the pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLINDAMYCIN PHOSPHATE (Clindamycin phosphate)

Snippet

SUPPL AP for CLINDAMYCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE)